E
Sell
3/28/2025Downgrade
IceCure Medical Ltd (ICCM) was downgraded to E+ from D- on 3/28/2025 due to a noticeable decline in the growth index, solvency index and valuation index. Debt to equity increased from 0.02 to 0.04, operating cash flow declined 77.53% from -$2.36M to -$4.2M, and EBIT declined 40.18% from -$3.23M to -$4.53M.
D
Sell
3/17/2025Upgraded
IceCure Medical Ltd (ICCM) was upgraded to D- from E+ on 3/17/2025 due to a large increase in the total return index and volatility index.
E
Sell
7/22/2024Downgrade
IceCure Medical Ltd (ICCM) was downgraded to E+ from D- on 7/22/2024 due to a decline in the total return index and volatility index.
D
Sell
7/5/2024Upgraded
IceCure Medical Ltd (ICCM) was upgraded to D- from E+ on 7/5/2024 due to an increase in the growth index and valuation index.
E
Sell
5/14/2024Downgrade
IceCure Medical Ltd (ICCM) was downgraded to E+ from D- on 5/14/2024 due to a noticeable decline in the solvency index, valuation index and total return index. Debt to equity increased from 0.01 to 0.02, and the quick ratio declined from 4.36 to 2.92.
D
Sell
3/14/2023Downgrade
IceCure Medical Ltd (ICCM) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
IceCure Medical Ltd (ICCM) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
IceCure Medical Ltd (ICCM) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the solvency index, total return index and growth index. Total revenue declined 44.73% from $1.38M to $765, the quick ratio declined from 6.57 to 4.14, and EBIT declined 36.86% from -$3.13M to -$4.28M.
D
Sell
5/5/2022Upgraded
IceCure Medical Ltd (ICCM) was upgraded to D from D- on 5/5/2022 due to an increase in the solvency index and total return index.
D
Sell
4/20/2022Downgrade
IceCure Medical Ltd (ICCM) was downgraded to D- from D on 4/20/2022 due to a major decline in the total return index, volatility index and growth index. Operating cash flow declined 231.03% from -$1.78M to -$5.89M, EBIT declined 67% from -$1.87M to -$3.13M, and earnings per share declined from -$0.0779 to -$0.0961.
D
Sell
11/23/2021Upgraded
IceCure Medical Ltd (ICCM) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
IceCure Medical Ltd (ICCM) was downgraded to D- from D on 11/8/2021 due to a major decline in the growth index.
D
Sell
9/29/2021None
IceCure Medical Ltd (ICCM) was downgraded to D from U on 09/29/2021.
